NASD · Healthcare · Health Information Services · USA
Aclarion Inc is a micro cap company (market value under $300 million) in the Health Information Services industry.
Aclarion is a healthcare technology company using Magnetic Resonance Spectroscopy and proprietary biomarkers to identify pain-causing spinal discs. The company offers NOCISCAN, a software platform that processes MRS data to assist surgeons in treatment planning for patients with chronic low back and neck pain, currently compatible with certain SIEMENS and PHILIPS MRI scanners.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Aclarion Inc stock.
Undervalued: intrinsic value $4.96 per share, market price $1.37, margin of safety 72.4% (as of 2026-11-17).
A 0.9x revenue multiple, discounted for its losses, values the shares at $4.96; the price of $1.37 is 72% below that value.
All 40 Health Information Services stocks
ACON is undervalued (as of the 2026-11-17 close). A 0.9x revenue multiple, discounted for its losses, values the shares at $4.96; the price of $1.37 is 72% below that value.
$4.96 per share (as of the 2026-11-17 close), against a market price of $1.37. That is a margin of safety of 72.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.